Jul 1, 2025 08:46AM
Jul 1, 2025 08:45AM
May 16, 2025 07:31AM
May 16, 2025 07:30AM
May 14, 2025 07:31AM
May 14, 2025 07:30AM
Mar 10, 2025 08:30AM Inozyme Pharma Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program and Recent Business Highlights
Nov 5, 2024 04:10PM
Nov 5, 2024 08:30AM
Aug 6, 2024 09:45AM
Aug 6, 2024 08:30AM
May 7, 2024 08:36AM
May 7, 2024 08:30AM
Mar 12, 2024 08:30AM Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights
Nov 7, 2023 08:30AM
Aug 8, 2023 08:30AM
Jul 26, 2023 07:31AM
Jul 26, 2023 07:30AM
May 9, 2023 08:30AM
Mar 22, 2023 08:30AM
Feb 16, 2023 07:30AM Inozyme Pharma (INZY) Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
Feb 16, 2023 07:30AM
Nov 10, 2022 08:30AM
Aug 15, 2022 07:30AM
May 10, 2022 07:30AM
Mar 16, 2022 04:29PM
Mar 15, 2022 05:29PM
Mar 15, 2022 05:24PM Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights
Nov 9, 2021 04:05PM
Aug 11, 2021 06:00AM
May 12, 2021 06:00AM
Mar 25, 2021 06:00AM
Nov 12, 2020 06:00AM
Sep 3, 2020 04:05PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All